HER-2 - A Possible Target for Therapy of Metastatic Urinary Bladder Carcinoma

Author： Wester Kenneth   Sjöström Anna   Torre Manuel De La   Carlsson Jörgen   Malmström Per-Uno  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.41, Iss.3, 2002-05, pp. : 282-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Transitional cell carcinoma of the urinary bladder metastatic to the oral mucosa

By Lee Kyu Seob   Song Ik Chan   Yun Hwan Jung   Jo Deog Yeon   Kim Samyong   Lee Hyo Jin  

Oncology Letters, Vol. 3, Iss. 2, 2012-02 ,pp. : 343-345

Spandidos Publications

Access to resources Recommend Favorite

HER2 as a target in invasive urothelial carcinoma

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 844-852

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of Resistance to HER2 Target Therapy

By Tortora Giampaolo  

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 43, 2011-10 ,pp. : 95-98

Oxford University Press

Access to resources Recommend Favorite

Second-line systemic therapy for metastatic urothelial carcinoma of the bladder

By Ortmann Christina Ann   Mazhar Danish  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1637-1651

Future Medicine

Access to resources Recommend Favorite

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

By Latif Z.   Watters A.D.   Dunn I.   Grigor K.   Underwood M.A.   Bartlett J.M.S.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite